Maryann Bruce, a Director at Amalgamated Financial Corp. (), disposed of 2,138 shares of common stock on July 30, 2026. The transactions totaled $105,942. The shares were sold at a weighted average price of $49.5522 per share. According to a footnote
Laura C. Kendall, a director at HomeTrust Bancshares, Inc. (), recently sold 10,000 shares of common stock for a total value of $511,348. The transactions, which occurred on July 30, 2026, also included the acquisition of 10,000 shares through the exercise
Cashio J. Richard, a director at ServisFirst Bancshares, Inc. (), disposed of common stock totaling $1,028,445 on July 31, 2026, according to a recent SEC Form 4 filing. The transaction involved the sale of 11,500 shares. The shares were sold at
James S. Abernethy, a director at Peoples Bancorp of North Carolina Inc. (), sold 1,000 shares of common stock on July 30, 2026, for a total value of $42,910. The shares were sold at a price of $42.91 per share, slightly
Ned S. Holmes, a director at Prosperity Bancshares Inc. (), sold shares totaling $81,685 on July 29, 2026. The transactions involved common stock sold at prices ranging between $72.84 and $74.3142 per share. The sales included both directly held shares and
Jonathan Sheena, a director and co-founder at Natera, Inc. (), sold shares totaling $123,548 over two separate transactions in late July 2026. The sales occurred at prices ranging from $254.0696 to $260.4908. On July 27, 2026, Sheena disposed of 288 shares of common
Theodor Werner Freye, a director at Valmont Industries (), sold 800 shares of the company’s common stock on July 27, 2026. The transaction totaled $396,000. The shares were sold at a price of $495.00 per share. Following this sale, Mr.
RA Capital Management, L.P., a reporting person identified as both a director and a 10% owner of Artiva Biotherapeutics, Inc. (), acquired 41,319 shares of the company’s common stock on July 24, 2026. The total value of these
Troy Cox, a director at MapLight Therapeutics, Inc. (), recently acquired 15,620 shares of the company’s common stock for a total value of $148,702. The transaction took place on July 28, 2026. The shares were purchased at a weighted
Curtland E. Fields, a director at Kearny Financial Corp. (), purchased shares of the company’s common stock on July 27, 2026. The transactions totaled $138,273, with prices ranging from $9.395 to $9.41 per share. The director made four separate purchases,
